Your browser doesn't support javascript.
loading
Robust Antitumor Effects of Combined Anti-CD4-Depleting Antibody and Anti-PD-1/PD-L1 Immune Checkpoint Antibody Treatment in Mice.
Ueha, Satoshi; Yokochi, Shoji; Ishiwata, Yoshiro; Ogiwara, Haru; Chand, Krishant; Nakajima, Takuya; Hachiga, Kosuke; Shichino, Shigeyuki; Terashima, Yuya; Toda, Etsuko; Shand, Francis H W; Kakimi, Kazuhiro; Ito, Satoru; Matsushima, Kouji.
Afiliación
  • Ueha S; Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Yokochi S; Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. IDAC Theranostics, Inc., Tokyo, Japan.
  • Ishiwata Y; Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. IDAC Theranostics, Inc., Tokyo, Japan.
  • Ogiwara H; Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Chand K; Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Nakajima T; Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Hachiga K; Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. IDAC Theranostics, Inc., Tokyo, Japan.
  • Shichino S; Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Terashima Y; Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Toda E; Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Shand FH; Department of Pharmacology and Therapeutics, The University of Melbourne, Melbourne, Victoria, Australia.
  • Kakimi K; Department of Immunotherapeutics, The University of Tokyo Hospital, Tokyo, Japan.
  • Ito S; Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. IDAC Theranostics, Inc., Tokyo, Japan.
  • Matsushima K; Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. koujim@m.u-tokyo.ac.jp.
Cancer Immunol Res ; 3(6): 631-40, 2015 Jun.
Article en En | MEDLINE | ID: mdl-25711759
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígenos CD4 / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Anticuerpos Monoclonales / Antineoplásicos Límite: Animals / Female / Humans / Male Idioma: En Revista: Cancer Immunol Res Año: 2015 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígenos CD4 / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Anticuerpos Monoclonales / Antineoplásicos Límite: Animals / Female / Humans / Male Idioma: En Revista: Cancer Immunol Res Año: 2015 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos